RAPAGEN Trademark

Trademark Overview

On Tuesday, January 10, 2012, a trademark application was filed for RAPAGEN with the United States Patent and Trademark Office. The USPTO has given the RAPAGEN trademark a serial number of 85512500. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 23, 2015. This trademark is owned by Vascular Therapies, LLC. The RAPAGEN trademark is filed in the Pharmaceutical Products category with the following description:

A combination drug product, namely, a formulation of sirolimus incorporated within a collagen membrane, which, as an implantable drug carrier, enables local delivery of sirolimus to the vascular wall
rapagen

General Information

Serial Number85512500
Word MarkRAPAGEN
Filing DateTuesday, January 10, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 23, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 19, 2012

Trademark Statements

Goods and ServicesA combination drug product, namely, a formulation of sirolimus incorporated within a collagen membrane, which, as an implantable drug carrier, enables local delivery of sirolimus to the vascular wall

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 13, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVASCULAR THERAPIES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCRESSKILL, NJ 07626
Party NameVascular Therapies, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCresskill, NJ 07626
Party NameVascular Therapies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCresskill, NJ 07626

Trademark Events

Event DateEvent Description
Monday, March 23, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 23, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 13, 2014EXTENSION 4 GRANTED
Thursday, August 7, 2014EXTENSION 4 FILED
Thursday, August 7, 2014TEAS EXTENSION RECEIVED
Tuesday, February 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 24, 2014EXTENSION 3 GRANTED
Friday, February 14, 2014EXTENSION 3 FILED
Thursday, February 20, 2014NOTICE OF REVIVAL - E-MAILED
Thursday, February 20, 2014EXTENSION RECEIVED WITH TEAS PETITION
Thursday, February 20, 2014PETITION TO REVIVE-GRANTED
Thursday, February 20, 2014TEAS PETITION TO REVIVE RECEIVED
Wednesday, September 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2013EXTENSION 2 GRANTED
Wednesday, August 14, 2013EXTENSION 2 FILED
Thursday, August 15, 2013NOTICE OF REVIVAL - E-MAILED
Thursday, August 15, 2013EXTENSION RECEIVED WITH TEAS PETITION
Thursday, August 15, 2013PETITION TO REVIVE-GRANTED
Thursday, August 15, 2013TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 11, 2013EXTENSION 1 GRANTED
Tuesday, January 29, 2013EXTENSION 1 FILED
Monday, February 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 29, 2013TEAS EXTENSION RECEIVED
Thursday, September 13, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 14, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 19, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 30, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 14, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 11, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 24, 2012EXAMINER'S AMENDMENT ENTERED
Tuesday, April 24, 2012ASSIGNED TO LIE
Monday, April 23, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 23, 2012EXAMINERS AMENDMENT E-MAILED
Monday, April 23, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 17, 2012ASSIGNED TO EXAMINER
Friday, January 13, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

rapagen sirolimus drug enables implantable local carrier delivery wall vascular which